Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Harvard Bioscience, Inc. (HBIO : NSDQ)

• Company Description    HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. Number of Employees: 355

• Price / Volume Information    Yesterday's Closing Price: $0.46 Daily Weekly Monthly 20 Day Moving Average: 1,134,859 shares Shares Outstanding: 44.21 (millions) Market Capitalization: $20.26 (millions) Beta: 1.52 52 Week High: $3.60 52 Week Low: $0.28 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -22.92% -25.24% 12 Week 16.02% 0.58% Year To Date -78.28% -79.48%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 84 OCTOBER HILL RD - HOLLISTON,MA 01746 USA ph: 508-893-8999 fax: 508-429-5732 hbio@threepa.com http://www.harvardbioscience.com

• General Corporate Information    Officers James Green - Chief Executive Officer and Director Jennifer Cote - Chief Financial Officer Katherine A. Eade - Director Alan Edrick - Director Thomas W. Loewald - Director Peer Information Harvard Bioscience, Inc. (DNEX) Harvard Bioscience, Inc. (T.PUR) Harvard Bioscience, Inc. (CALP.) Harvard Bioscience, Inc. (CCSI.) Harvard Bioscience, Inc. (NEWP.) Harvard Bioscience, Inc. (PBSC) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: INSTRU-SCIENTFC Sector: Computer and Technology CUSIP: 416906105 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/14/25 Share - Related Items Shares Outstanding: 44.21 Most Recent Split Date: (:1) Beta: 1.52 Market Capitalization: $20.26 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.00 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.00 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/14/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.37 Price/Cash Flow: 4.54 Price / Sales: 0.22 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -150.00% Sales Growth vs. Year Ago Period: -11.17% vs. Previous Quarter: -11.33% ROE 06/30/25 - - 03/31/25 - -4.96 12/31/24 - -2.74 ROA 06/30/25 - - 03/31/25 - -2.24 12/31/24 - -1.40 Current Ratio 06/30/25 - - 03/31/25 - 0.81 12/31/24 - 0.82 Quick Ratio 06/30/25 - - 03/31/25 - 0.40 12/31/24 - 0.40 Operating Margin 06/30/25 - - 03/31/25 - -2.86 12/31/24 - -1.93 Net Margin 06/30/25 - - 03/31/25 - -63.51 12/31/24 - -13.18 Pre-Tax Margin 06/30/25 - - 03/31/25 - -63.43 12/31/24 - -12.39 Book Value 06/30/25 - - 03/31/25 - 0.34 12/31/24 - 1.45 Inventory Turnover 06/30/25 - - 03/31/25 - 1.61 12/31/24 - 1.60 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©